Argus
•
Apr 29, 2026
AVTR: Lowering target price to $7.00
Summary
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced t
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
WST: Raising target price to $343.00
May 13, 2026
•
WST
APLS: What does Argus have to say about APLS?
May 13, 2026
•
APLS
BIO: Lowering target price to $230.00
May 13, 2026
•
BIO
NVST: Lowering target price to $25.00
May 13, 2026
•
NVST
AXTA: What does Argus have to say about AXTA?
May 13, 2026
•
AXTA
